MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at Jesup and Lamont's 2008 Emerging Growth Stock Conference on February 28, 2008 at the Walt Disney Contemporary resort in Orlando, FL. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will present the company's business strategy and financial results on February 28, 2008, at 8:15 a.m. Eastern Standard Time (5:15 a.m. PST).
Attendance at the conference is by invitation only. A live webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at Jesup and Lamont's website at http://www.jesuplamontconferences.com. You must first register to have access to the webcast.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug
development success: strong decision-making. By adopting the Pharsight
approach, customers acquire a new decision-making process with the
potential to systematically improve every level and phase of their business
and scientific proce
|SOURCE Pharsight Corporation|
Copyright©2008 PR Newswire.
All rights reserved